amprenavir has been researched along with Allergy, Drug in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huynh, P; Kohli-Pamnani, A; Lobo, F | 1 |
| Arnold, E; Das, K; Limoli, K; Parkin, NT; Petropoulos, CJ; Ziermann, R | 1 |
| Bartnof, HS | 1 |
| Corral, A; de Mendoza, C; Gallego, O; Soriano, V | 1 |
4 other study(ies) available for amprenavir and Allergy, Drug
| Article | Year |
|---|---|
Amprenavir-induced maculopapular exanthem followed by desensitization in a patient with late-stage human immunodeficiency virus.
Topics: Adult; Carbamates; Desensitization, Immunologic; Drug Hypersensitivity; Exanthema; Female; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Sulfonamides | 2006 |
A mutation in human immunodeficiency virus type 1 protease, N88S, that causes in vitro hypersensitivity to amprenavir.
Topics: Anti-HIV Agents; Carbamates; Drug Hypersensitivity; Furans; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Mutagenesis, Site-Directed; Sulfonamides | 2000 |
Selected highlights from the 5th Conference on Retroviruses and Opportunistic Infections.
Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antiviral Agents; Benzoxazines; Carbamates; Chicago; Clinical Trials as Topic; Congresses as Topic; Cyclopropanes; Dideoxynucleosides; Drug Hypersensitivity; Drug Interactions; Drug Therapy, Combination; Drugs, Investigational; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxyurea; Oxazines; Reverse Transcriptase Inhibitors; Sulfonamides | 1998 |
Prevalence of the HIV protease mutation N88S causing hypersensitivity to amprenavir.
Topics: Amino Acid Substitution; Anti-HIV Agents; Asparagine; Carbamates; Drug Hypersensitivity; Furans; Gene Frequency; HIV; HIV Protease; Humans; Mutation; Serine; Sulfonamides | 2002 |